Volume 24 • No. 3 • March 2000

DeMerger to be official April 1

Dean search expected to give VP more time for clinical leadership

Home Care services to operate separately

Former associate dean Steward dies

Body Image study

The accomplishments of your colleagues and associates
are making a significant impact.
Detailed news releases and/or source material
are available at the
News Bureau of the Stanford University
Medical Center Office of News and Public Affairs,
701 Welch Road, Suite 2207, Palo Alto, CA 94304;
phone (650) 725-5376 or 723-6911;
and on the World Wide Web
(http://www-med.stanford.edu/center/communications/).

AOVMs - A study of 56 patients from 1990 to 1998 shows for the first time that innovative surgical techniques and lots of experience can aid surgeons in safely removing deep angiographically occult vascular malformations. Gary Steinberg, professor and chair of neurosurgery, was lead author of a paper in the February issue of Neurosurgery, which described how mapping and altering the surgical site based on the location of the lesion can improve safety and outcome for AOVM patients.
B-CELL LYMPHOMA - Through genetic analysis, Stanford researchers led by Patrick Brown, a Howard Hughes investigator and associate professor of biochemistry, have found that the DLBCL form of B-cell lymphoma is actually two diseases rather than one. Publishing in the Feb. 3 issue of Nature, the multi-center study is expected to allow clinicians to fine-tune treatment strategies based on the precise form of the lymphoma.

STROKE - Neurologists and emergency room physicians throughout the United States can safely administer t-PA, according to a multi-center study that also shows that the minor risk of intracranial hemorrhage after t-PA treatment does not outweigh the clear benefits of the drug for most patients. Gregory Albers, professor of neurology and director of the Stanford Stroke Center, was lead author of the paper, which appeared in the March 1 issue of the Journal of the American Medical Association.

DNA CHIP - Using color tags, scientists can look at which genes are switched on and off in a variety of cancers and learn what thousands of our genes do and why their behavior changes in malignant cells. Results of studies using a so-called DNA chip was published in the March 1 issue of Nature Genetics by Stanford authors including Patrick Brown, a Howard Hughes Investigator and associate professor in biochemistry; David Botstein, professor of genetics; and Doug Ross, a postdoctoral fellow in biochemistry.

HEMOPHILIA B - The first three patients treated in a gene therapy trial designed to test a new treatment for hemophilia B showed no adverse effects, and there were signs that the patients' condition improved as a result of the treatment, according to a paper published in the March issue of Nature Genetics. The co-author of the research, conducted at Stanford and at Children's Hospital of Philadelphia, was Mark Kay, associate professor of pediatrics and of genetics, and director of the Stanford's program in human gene therapy.
Back to Top